Progressive Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Progressive Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients [Phase 2]
Phase 2 clinical trial investigating HEC585 to delay decline in forced vital capacity in progressive fibrosing interstitial lung disease, cu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of inhaled treprostinil for progressive pulmonary fibrosis, with recruitment …
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis [Phase 3]
Phase 3 study of BMS-986278 for progressive pulmonary fibrosis is currently active but not recruiting, according to clinical trial updates.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast [Phase 3]
A Phase 3 follow-up trial is planned to assess long-term treatment with Nerandomilast in people with idiopathic pulmonary fibrosis or progre…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease [Phase 3]
This is a Phase 3 extension study of inhaled treprostinil for fibrotic lung diseases, sponsored by United Therapeutics, with enrollment by i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) [Phase 2]
A Phase 2 extension study for subjects who received Avalyn's inhaled antifibrotic agent (SAIL) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Xenon MRI and Progressive ILD [Phase 2]
A Phase 2 Duke University trial is investigating Xenon MRI imaging for progressive interstitial lung diseases, including idiopathic pulmonar…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis [Phase 2]
Phase 2 study of BI 1839100 for cough in idiopathic pulmonary fibrosis or progressive pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications
A pilot clinical trial evaluating body composition measurement using bioelectrical impedance analysis and muscle ultrasound in patients with…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
A clinical trial update announcing a prospective phenotyping and multi-omic endotyping study of progressive pulmonary fibrosis. The study is…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: A Trial of HRS-9813 in Healthy Subjects [Phase 1]
Phase 1 clinical trial evaluating HRS-9813 in healthy subjects, sponsored by Guangdong Hengrui Pharmaceutical, with listed conditions includ…